Organogenesis Holdings (ORGO) Stock Price, Quote, News & History | Benzinga

Organogenesis Holdings Inc (ORGO) Stock Price, Quote, News & History

ORGONASDAQ

Trade with Public

Trade with Public

$1.91

0.126.7%

At close: Aug 19, 5:00 PM EST

$1.88

-0.03-1.57%

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.80

Close

$1.91

Volume / Avg.

604.76K / 886.16K

Day Range

$1.80 - $1.95

52 Wk Range

1.54 - 7.08

Market Cap

$241.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

16.28%

Days to Cover

20.82

Recent Organogenesis Holdings Inc. News

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

US stock futures mixed, Nasdaq 100 futures up 100 points. Trade Desk Inc shares down 27.7% after weak Q2 results. Other stocks also lower premarket.

Avi Kapoor

Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket

Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. Stock jumped 30.7% in pre-market trading.

Avi Kapoor

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Pegasystems Inc (NASDAQ: PEGA) reported lower-than-expected earnings and sales, causing stocks to fall 16% in pre-market trading.

Avi Kapoor

Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading. Other stocks also decline.

Avi Kapoor

Ryanair Posts Weak Q1 Results, Joins HDFC Bank And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 results. Other stocks declining in pre-market.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

31.97M

Investing Cash Flow (TTM)

-11.13M

Financing Cash Flow (TTM)

-47.73M

Free Cash Flow (TTM)

20.84M

Capital Expenditure (TTM)

-11.13M

Net Change in Cash (TTM)

-26.89M

Analyst Trends and Forecast

1

Feb

1

Mar

0

0

0

0

May

0

0

0

0

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$390.40M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.51

PB Ratio (TTM)

1.55

Earnings Yield % (TTM)

-44.26%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

11.23

Book Value / Share

$1.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$10.79M

Total Cash

$46.10M

Debt to Equity

0.45

Issuance of Debt (TTM)

-$10.79M

Repayment of Debt (TTM)

-$10.79M

Key Statistics

Open

$1.80

Close

$1.91

Volume / Avg.

604.76K / 886.16K

Day Range

$1.80 - $1.95

52 Wk Range

1.54 - 7.08

Market Cap

$241.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

16.28%

Days to Cover

20.82

About

Sector

Health Care

Industry

Biotechnology

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerat...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Organogenesis Holdings (ORGO) stock?

A

You can purchase shares of Organogenesis Holdings (NASDAQ:ORGO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Organogenesis Holdings (ORGO) competitors?

A

Other companies in Organogenesis Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Organogenesis Holdings (ORGO) stock?

A

Organogenesis Holdings has a consensus price target of $6.00.

Q

What is the current price for Organogenesis Holdings (ORGO)?

A

The stock price for Organogenesis Holdings (NASDAQ: ORGO) is $1.88 last updated August 19, 2026 at 4:00 PM EDT.

Q

Does Organogenesis Holdings (ORGO) pay a dividend?

A

There are no upcoming dividends for Organogenesis Holdings.

Q

When is Organogenesis Holdings (NASDAQ:ORGO) reporting earnings?

A

Organogenesis Holdings does not have any upcoming earnings scheduled.

Q

Is Organogenesis Holdings (ORGO) going to split?

A

There is no upcoming split for Organogenesis Holdings.

Q

What sector and industry does Organogenesis Holdings (ORGO) operate in?

A

Organogenesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.